- Home
- NDRA vs AIMD Comparison
NDRA vs AIMD Comparison
Compare NDRA & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- AIMD
- Stock Information
- Founded
- NDRA 2007
- AIMD 1984
- Country
- NDRA United States
- AIMD United States
- Employees
- NDRA N/A
- AIMD N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- NDRA Health Care
- AIMD Health Care
- Exchange
- NDRA Nasdaq
- AIMD Nasdaq
- Market Cap
- NDRA 3.7M
- AIMD 5.2M
- IPO Year
- NDRA 2017
- AIMD N/A
- Fundamental
- Price
- NDRA $0.21
- AIMD $0.55
- Analyst Decision
- NDRA Strong Buy
- AIMD
- Analyst Count
- NDRA 1
- AIMD 0
- Target Price
- NDRA $400.00
- AIMD N/A
- AVG Volume (30 Days)
- NDRA 1.3M
- AIMD 769.6K
- Earning Date
- NDRA 11-12-2024
- AIMD 11-07-2024
- Dividend Yield
- NDRA N/A
- AIMD N/A
- EPS Growth
- NDRA N/A
- AIMD N/A
- EPS
- NDRA N/A
- AIMD N/A
- Revenue
- NDRA N/A
- AIMD $65,122.00
- Revenue This Year
- NDRA N/A
- AIMD N/A
- Revenue Next Year
- NDRA N/A
- AIMD N/A
- P/E Ratio
- NDRA N/A
- AIMD N/A
- Revenue Growth
- NDRA N/A
- AIMD N/A
- 52 Week Low
- NDRA $0.18
- AIMD $0.45
- 52 Week High
- NDRA $139.50
- AIMD $4.29
- Technical
- Relative Strength Index (RSI)
- NDRA 24.71
- AIMD 54.23
- Support Level
- NDRA $0.20
- AIMD $0.46
- Resistance Level
- NDRA $0.22
- AIMD $0.52
- Average True Range (ATR)
- NDRA 0.01
- AIMD 0.04
- MACD
- NDRA 0.06
- AIMD 0.01
- Stochastic Oscillator
- NDRA 64.36
- AIMD 67.73
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.